newcleo plc Reports First Half 2026 Financial and Operational Results
Key Highlights
- ➤Business combination generated approximately $247 million gross proceeds for newcleo (NWCL)
- ➤NWCL and NWCLW began Nasdaq Global Select Market trading September 22, 2026
- ➤First-half revenue €19.4 million, up approximately 46% year over year
- ➤First-half net loss €82.0 million, up approximately 10% year over year
- ➤Preliminary September 30 cash approximately €233 million after financing proceeds
Expert Statements
Stefano Buono, Founder and CEO of newcleo
“Becoming a public company is a defining milestone for newcleo, and I want to thank every member of our team for the work that brought us to this point and to reporting our first results as a public company.”
Stefano Buono, Founder and CEO of newcleo
“Access to the public markets strengthens our ability to execute on our mission to deliver a credible, near-term path to advanced nuclear deployment and to close the nuclear fuel cycle.”
Stefano Buono, Founder and CEO of newcleo
“Importantly, newcleo is moving quickly down the path to both technical validation and regulatory approval for our facilities.”
Stefano Buono, Founder and CEO of newcleo
“The installation of the main vessel for PRECURSOR, our 10 MWt non-nuclear demonstration reactor at Brasimone, is a development milestone for the LFR technology ahead of planned commercial deployment.”
Stefano Buono, Founder and CEO of newcleo
“Completion of construction for PRECURSOR, which is expected by the end of 2026, and beginning the process of reactor system validation, are the next critical steps in qualifying the technology that will lead to the deployment of our LFR-200 reactor.”
Stefano Buono, Founder and CEO of newcleo
“Our U.S. growth is a particular focus: our work toward siting at Savannah River, and the broader policy support for nuclear expansion in the U.S., position newcleo to play a meaningful role in meeting U.S. energy demand, including from AI infrastructure.”
Elisabeth Rizzotti, Co-Founder, Deputy-CEO and COO of newcleo
“In the first half of 2026, newcleo continued moving our operations forward, continuing to convert planning into reality.”
Elisabeth Rizzotti, Co-Founder, Deputy-CEO and COO of newcleo
“Our OTHELLO test loop is operating, PRECURSOR is under active construction at Brasimone with major components manufactured and installed by our own vertically integrated subsidiaries, which gives us direct control over cost, schedule, and quality across the supply chain rather than relying on third parties for critical systems.”
Elisabeth Rizzotti, Co-Founder, Deputy-CEO and COO of newcleo
“At the same time, our work with trusted partners continues to translate into concrete engineering and commercial work.”
Elisabeth Rizzotti, Co-Founder, Deputy-CEO and COO of newcleo
“Each of these efforts, testing, building, manufacturing, and partnering, reflects the same discipline: turning our technology roadmap into physical progress on the ground.”
First Half 2026 and Subsequent Commercial and Operational Highlights * Completed business combination with NewHold Investment Corp III (“SPAC”) on September 21, 2026 (the “Business Combination”); newcleo’s ordinary shares and warrants commenced trading on the Nasdaq Global Select Market on September 22, 2026 under the symbols “NWCL” and “NWCLW,” respectively * The Business Combination generated gross proceeds of approximately $247 million, consisting of approximately $31 million released from the SPAC’s trust account and $216 million from the PIPE financing * Raised approximately $18.7 million in additional financing unrelated to the Business Combination since May 2026, bringing total funds raised since newcleo’s founding to over $1 billion * Installed the main vessel and turbine for its PRECURSOR non-nuclear 10 MWt demonstration reactor at the ENEA Brasimone Research Center outside Bologna, Italy; completion of construction for PRECURSOR is expected by the end of 2026, with at-scale validation of systems to commence thereafter * In partnership with Oklo, selected by the U.S. Department of Energy for advanced negotiations under the Surplus Plutonium Utilization Program * Submitted Regulatory Engagement Plans to the U.S. Nuclear Regulatory Commission for the Company’s LFR-AS-200 lead-cooled fast reactor and its planned U.S. mixed-oxide (MOX) fuel manufacturing facility * Received notice of an overall opinion of satisfactory compliance from the French Nuclear Safety and Radiation Protection Authority for the proposed safety features for the Company’s planned MOX fuel manufacturing facility in France * Announced the acquisition, subject to customary closing conditions, of Bonifait Pesage, a French manufacturer of nuclear-grade scales and precision industrial weighing equipment, augmenting the Company’s vertically integrated capabilities * Announced the appointment of Jeffrey Lyash, a nuclear industry veteran and former head of the Tennessee Valley Authority, as Chairman of the Board of Directors * Announced the appointment of William D. Magwood as Vice-Chairman of newcleo’s Board of Directors, effective January 1, 2027 * Announced the hiring of Dustin Greenwood as Vice President of U.S. Operations and Travis Chapman as Director of U.S. Regulatory Affairs and Licensing, strengthening the Company’s growing U.S. team * Announced a partnership with SHINE to assess and jointly pursue opportunities relating to nuclear fuel recycling in the United States and European Union * On September 10, 2026, newcleo held an Analyst and Investor Day, a recording of which is available on newcleo’s website First Half 2026 Financial Highlights * Generated Revenue from Products and Services of approximately €19.4 million, an increase of approximately 46% over First Half 2025 * Reported Net Loss of approximately €82.0 million, an increase of approximately 10% over First Half 2025 * Reported Tangible Capital Expenditures of €25.3 million, an increase of 37% over First Half 2025 * Reported Selling, General & Administrative expenses of €59.2 million, an approximately 21% increase over First Half 2025 * Cash & Cash Equivalents as of June 30, 2026 stood at €66.5 million * Total ordinary shares outstanding as of the closing date of the Business Combination stood at 281,534,950 * As of September 30, 2026, preliminary, unaudited Cash & Cash Equivalents for the Company stood at approximately €233 million LONDON, Oct. 02, 2026 (GLOBE NEWSWIRE) -- newcleo plc (Nasdaq: NWCL) (“newcleo” or the “Company”), a pioneer in advanced modular reactor (“AMR”) technology and nuclear fuel manufacturing, today announced its operational and financial results for the six months ended June 30, 2026.
Get started
Create a free account to read the full story.
